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Summary: Bilirubin causes certain defects in erythrocyte metabolism, mainly in glycolysis. These effects of bilirubin
were studied in vitro using a relatively physiological assay medium, which consisted of heparinized whole blood.
Bilirubin was added in a small quantity of NaOH solution. In the presence of bilirubin a reduced glucose consumption
of red cells and an accelerated depletion in the ATP and glycerate-2,3-bisphosphate concentration was found. Bili-
rubin levels lower than 50 /l did not influence the glucose consumption. In agreement to other investigations
it was established that biblirubin causes haemolysis of red cells. ATP-deficient cells are more sensitive to this effect.
Zur Wirkung von Bilirubin auf den Erythrocytenstoffwechsel
Zusammenfassung: Bilirubin ruft bestimmte Veränderungen im Erythrocytenstoffwechsel hervor, die hauptsächlich
die Glykolyse betreffen. Diese Wirkungen von Bilirubin wurden in vitro an Hand eines vergleichsweise physiologischen
Versuchsansatzes untersucht, der aus heparinisiertem Vollblut bestand. In das Vollblut wurde eine kleine Menge
Natronlauge mit dem darin gelösten Bilirubin einpipettiert. In Gegenwart von Bilirubin wurde eine Hemmung des
Glucoseverbrauches der Erythrocyten und ein beschleunigter Abfall von ATP und Glycerat-2,3-biphosphat beobachtet.
Unterhalb einer Bilirübinkonzentration von 50 /l ließ sich eine Hemmung des Glucoseverbrauches nicht mehr
nachweisen. In Übereinstimmung mit anderen Untersuchungen wurde festgestellt, daß Bilirubin eine Hämolyse verur-
sachen kann. ATP-arme Erythrocyten sind gegenüber dieser Wirkung von Bilirubin besonders empfindlich.
Introduction
An elevated level of uncönjugated serum bilirubin is
most frequently found during the newborn period.
A rapid increase of bilirubin and high values in many
patients are caused by a serologic incompatibility
between mother and child. If an incompatibility cannot
be confirmed, transitory hyperbilirubinäemia is the
most frequently assumed explanation for the elevated
bilirubin concentrations.
The question of whether foilirubin itself participates in
the etiology of transitory hyperbilirubinaemia is of
great interest. As early as 1966 Cheung et al. demon-
strated that bilirubin interferes with red cell metabolism
(1). When red cells are incubated with bilirubin they
consume less glucose and the ATP concentration drops
more rapidly compared-with samples incubated in the
absence of buirubin. These results were confirmed by
later authors, who additionally reported an inhibition
of membrane ATPase and a haemolysis of red cells
induced by bilirubin (2, 3).
So far, however, published studies concerning the effects
of bilirubin on red cells in vitro are difficult to compare
with those reported in vivo. In all studies bilirubin was
dissolved in a buffer and red cells were added. Bilirubin,
however, is not soluble in aqueous solutions at a physio-
logical pH value. The pH has to be increased to a value
of about 8.0. This is accompanied by an inevitable in-
crease in red cell glycolysis (4, 5). Furthermore the
suspension of red cells in a buffer results in a reduced
pentose phosphate pathway (6). These disadvantages
can easily be avoided by dissolving bilirubin in NaOH and
adding a small amount of this solution directly into
whole blood. The necessary amount of NaOH can be
limited to such a small quantity that the increase in the
pH is minimal. Using this model the effects of bilirubin
on red cell integrity, glucose consumption and the
content of organic phosphates were examined.
Methods
Bilirubin was dissolved in 1 ml NaOH (0.1 mol/1) and 10 of
this solution were added to 2 ml of heparinized blood from a
healthy adult donor. The sample was incubated without further
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additives at 37 °C in the daik. A blank sample from the same
donor was prepared exactly in the same way, containing the
same amount of NaOH without bilirubin. In both samples the
leukocytes were removed by discarding the buffy coat layer
after centrifugation. The quantity of bilirubin dissolved in the
NaOH was chosen so that the final bilirubin concentrations
were 70-80 μηιοΐ/ΐ.
At intervals of 2 hours the contents of ATP (7), ADP (8), AMP
(8), glycerate-2,3-bisphosphate (9), and glucose (10) were
determined in both samples by standard laboratory methods.
Bilirubin-induced haemolysis was measured by determination
of the free haemoglobin in the plasma. 200 μΐ of the super-
natant were added to 5 ml of cyanhaemiglobin solution and the
absorbance was read against pure cyanhaemiglobin. Bilirubin
determination were performed according to the method of
Jendrassik & Grof (11).
To prove a significant difference between the bilirubin-con-
taining sample and the blank sample the paired t-test was
used. A significant difference was assumed in those investi-
gations when p was found to be less than 0.05.
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Fig. 1. Mean value and standard deviation of the glucose con-
centration in the bilirubin containing sample ( ) and
the blank sample (*—?-) at different intervals. The
difference is significant at 4 and 6 hours.
Results
Glucose consumption of red cells
The'glucose consumption of the erythrocytes was found
to be lowered in the bilirubin-containing sample, com-
pared to the blank sample (fig. 1). The effect of bili-
rubin is significant after an incubation time of 4 hours
(tpaired = 5.8), and 6 hours (tpaired = 9.2). The final bili-
rubin concentrations in these experiments ranged from
70—80 μιηοΐ/l. The increase in the pH after addition of
the bilirubin-containing NaOH to the heparinized blood
sample was found to be minimal. In five experiments the
initial pH values ranged from 7.38 to 7.41, after addition
of the NaOH from 7.43 to 7.46.
Glycerate-2,3-bisphosphate, ATP, ADP, and AMP lev eh
Glycerate-2,3-biphosphate as well as ATP decrease signi-
ficantly and more rapidly in the presence of bilirubin
(fig. 2 and 3). These results are significant at each time
period of the investigation (tpaired for glycerate-2,3-
biphosphate at 2,4, and 6 hours = 19.9,42.4, 6.7;
tpaired for ATP = 9.8,10.5 and 6.2). ADP and AMP
levels, on the other hand, are not influenced by bilirubin.
Table 1 gives the concentrations of these organic phos-
phates. No reliable differences can be recognized.
Bilirubin-induced haemolysis of red cells and ATP levels
Bilirubin induces haemolysis of red cells at a concentra-
tion between 70-80 μηιοΐ/ΐ after a period of 4 hours.
Haemolysis increases rapidly during further investiga-
tion (fig. 4). The blank sample shows a minimal haemo-
lysis after an incubation time of 8 hours.
The regression line is described by the equation
y = 1.92e°-37x. The relationship of time to haemolysis
is significant (r = 0.531, ρ < 0.001, η = 24). Figure 5
shows the relationship of the measured ATP concentra-
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Fig. 2. Mean value and standard deviation of the glycerate-2,3-
biphosphate concentration in red cells in the presence
of bilirubin (— ; — ) as compared to a blank sample
(— — ). In the bilirubin containing sampleglycerate-2,3-
bisphosphate is significantly lower at each time of investi-
gation.
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Fig. 3.
T i m e l h )
Mean value and standard deviation of the ATP concen-
tration iri red cells in the presence of bilirubin ( ) as
compared to a blank sample (——). ATP levels are
lower in the bilirubin-containing assay.
tion in the red cells versus the degree of haemolysis. The
significance can also be confirmed between these two
parameters (y = 12.6e~°·01 *x, r = - 0.676, p < 0.01,
n = 24).
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Tab. 1. ADP and AMP concentrations in whole blood containing bilirubin in a concentration of 70-80 jumol/l at different periods of
incubation. The results are compared to a blank sample, which contains no bilirubin. No reliable differences between the two
assays can be recognized.
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Fig. 4. Relationship of the bilirubin-induced haemolysis versus
time. After an incubation period of four hours bili-
rubin causes haemolysis of red cells, which cannot be
demonstrated in the blank sample until eight hours, and
then to a far lesser extent (· = bilirubin containing
sample, ο = sample free of bilirubin).
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Fig. 6. Minimal effective bilirubin concentration which is able to
inhibit glucose consumption of red cells. Below a bili-
rubin concentration of 50 μηιοΐ/ΐ there is no difference
between the test and a bilirubin free sample; bilirubin con-
centrations greater than 60 μπιοΙ/1 result in a decreased
glucose consumption. The vertical axis of the figure
shows the difference in the glucose concentration
between the bilirubin containing and bilirubin free
sample.
·,*·'
0.15
0.14
jO.13
ο
laio
ao9
ao6
Q05
10 20 30 40 50 60
Plasma haemoglobin lmg/11
70 80
Fig. 5. Relationship of bilAmbirHnduced haemolysis versus
ATP levels of the red cells. The relationship is signi-
cant (see text).
Minimal effective bilirubin concentration
To determine the lowest bilirubin concentration which
is able to inhibit erythrocyte metabolism, the glucose com
sumption of red cells was measured at different bilirubin
concentrations. Figure 6 shows the results of these experl·
ments. The difference in the glucose concentration be-
tween the bilirubin-containing sample and the blank
sample is registered on the vertical axis, while the bili-
rubin level is given on the horizontal axis. Results are
given separately for an incubation time of 2 and 4 hours.
Bilirubin concentrations below 50 μπιοΙ/1 do not in-
hibit the glucose consumption. At values above 60 μπιοΙ/1
it is reduced, and this can be seen from the higher glucose
concentration in the bilirubin-containing blood sample.
Thus a bilirubin concentration between 50 and 60
μιηοΐ/ΐ has to be regarded as critical for erythrocyte
metabolism.
Discussion
Our study confirms earlier reports (1) that bilirubin
inhibits the glucose consumption of red cells and
causes an ATP depletion. Additionally an accelerated
decrease in the glycerate-2,3-bisphosphate concentra-
tion was observed. These effects can be demonstrated at
comparatively low bilirubin concentrations and in the
·'*%
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presence of physiological concentrations of all plasma
components. The ATP and glycerate-2,3-bisphosphate
depletion can be explained by the inhibited glucose con-
sumption, as the synthesis of both of these organic
phosphates depends upon an adequate glucose supply
to the red cell.
The reduced glucose consumption can be explained either
by an inhibition of red cell glycolysis or by a reduced
glucose uptake through the membrane. Although an
inhibition of glycolysis is not excluded, the impairment
of the glucose uptake appears more likely. Thus Girotti
et al. (12) demonstrated, in the presence of bilirubin,
slight modifications in the red cell membrane proteins,
some of which are important for active glucose transport
through the membrane (13). Inhibition of the membrane
ATPase also indicates the primary action of bilirulbin at
the membrane.
The inhibition of glucose consumption in red cells is
caused by bilirubin concentrations, which can easily be
found in many newborns during the first days of life.
The critical bilirubin level has been estimated to be
about 60 / . This is far below the value determined
by Cheung et al. (1). An advantage of our experiments
is the presence of all normal plasma components during
the incubation period. This is especially important for
albumin because of its bilirubin binding properties (14).
However, even at low concentrations of bilirubin a
steady state exists between the binding to albumin and
the binding to the red cells (15). In accordance with
earlier investigations it was observed that bilirubin in-
duces haemolysis of red cells (2, 3, 16). The degree of
haemolysis depends upon the time bilirubin acts on
the erythrocytes. In an earlier investigation we found a
significant relationship between biiirubin-induced
haemolysis and the ATP concentration within the red
cells (16). This relationship could be confirmed by in-
cubating ATP depleted red cells with inosine, thus
increasing the ATP level and reducing haemolysis.
Although this study was performed by suspending red
cells in a buffer, our present results support this relation-
ship.
The inhibitory effects of bilirubin on red cell glucose
consumption and its haemolytic effect appear to be
significant especially during the newborn period.
As recent investigations have recognized haemolysis as an
important factor in newborns suffering from transitory
hyperbilirubinaemia (17,18), it is speculated that
similar effects of bilirubin to the described in vitro re^
suits could be of importance for the clinical course of
this abnormality.
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